Back
Kiniksa Pharmaceuticals Vs. Affirm Holdings Industry Stock Comparison
Buy
56
KNSA
Kiniksa Pharmaceuticals
Last Price:
18.98
Seasonality Move:
0.39%
Buy
70
AFRM
Affirm Holdings
Last Price:
32.98
Seasonality Move:
37.05%
Buy
56
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Is Kiniksa Pharmaceuticals a Buy, Sell or Hold?
- The current Kiniksa Pharmaceuticals [KNSA] share price is $18.86. The Score for KNSA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- KNSA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Affirm Holdings (AFRM)
is a Buy
Is Affirm Holdings a Buy, Sell or Hold?
- The current Affirm Holdings [AFRM] share price is $33.70. The Score for AFRM is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- AFRM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KNSA Stock Price Chart
What is Kiniksa Pharmaceuticals's stock price today?
-
The Kiniksa Pharmaceuticals share price today is $18.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KNSA is experiencing slight buying pressure.
AFRM Stock Price Chart
What is Affirm Holdings's stock price today?
-
The Affirm Holdings share price today is $33.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AFRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
KNSA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 49.24 | Sell |
| Chaikin Money Flow: | 69075 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.56 - 19.48) | Sell |
| Bollinger Bands (100): | (18.14 - 20.3) | Sell |
AFRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 56.55 | Buy |
| Chaikin Money Flow: | 9632125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.27 - 32.89) | Buy |
| Bollinger Bands (100): | (30.74 - 38.8) | Sell |
KNSA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.58 | Buy |
| 20-day SMA: | 18.91 | Sell |
| 50-day SMA: | 18.85 | Buy |
| 200-day SMA: | 18.12 | Buy |
| 8-day EMA: | 18.64 | Buy |
| 20-day EMA: | 18.86 | Buy |
| 50-day EMA: | 18.98 | Sell |
| 200-day EMA: | 18.08 | Buy |
AFRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.89 | Buy |
| 20-day SMA: | 30.88 | Buy |
| 50-day SMA: | 31.82 | Buy |
| 200-day SMA: | 32.65 | Buy |
| 8-day EMA: | 31.53 | Buy |
| 20-day EMA: | 31.44 | Buy |
| 50-day EMA: | 32.27 | Buy |
| 200-day EMA: | 31.49 | Buy |
Kiniksa Pharmaceuticals Earnings Growth & KNSA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.49 per share.
Affirm Holdings Earnings Growth & AFRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.10 per share, and an increase next year of $0.04 per share.
Kiniksa Pharmaceuticals Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Affirm Holdings Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||